Guo Guangchang: Fosun International's NAV reaches HKD18.1 Per Share, Focusing Resources on Core, High‑Growth Areas

Rhea-AI Summary

Fosun International (OTC:FOSUF) reported 2025 results and management commentary on March 31, 2026. Adjusted NAV totaled RMB133.5 billion, with a NAV per share of HKD18.1. Group revenue was RMB173.43 billion and adjusted industrial operation profit was RMB4.0 billion.

The company booked a non-cash book loss of RMB23.4 billion from impairments (≈55% real estate, ≈45% non-core goodwill/intangibles). Management announced a share buyback program, insiders and the major shareholder will increase holdings, and said it will focus resources on core, high-growth businesses.

Positive

• Adjusted NAV RMB133.5 billion
• NAV per share HKD18.1
• Total revenue RMB173.43 billion
• Adjusted industrial operation profit RMB4.0 billion
• Fosun Pharma net profit +21.69% (RMB3.371 billion)
• Fosun Insurance Portugal net profit EUR201 million (+15.8%)

Negative

• Non-cash book loss RMB23.4 billion from impairments
• Real estate-related impairment ≈55% of total impairment
• Impairment of non-core goodwill/intangibles ≈45% of total impairment

Market Context

This announcement outlines a major clean-up of non-core and lower-performing assets, with a RMB23.4 ...

Analysis

This announcement outlines a major clean-up of non-core and lower-performing assets, with a RMB23.4 billion non-cash impairment alongside stable revenue of RMB173.43 billion and adjusted NAV of RMB133.5 billion. Management highlights stronger contributions from pharmaceuticals and insurance plus a planned share buyback. Investors may watch how future results track reported NAV per share of HKD18.1, the profitability of core segments, and any further divestments of real estate and non-core operations.

Key Figures

Adjusted NAV: RMB133.5 billion NAV per share: HKD18.1 Impairment provisions: RMB23.4 billion +5 more

8 metrics

Adjusted NAV RMB133.5 billion Fosun International adjusted net asset value

NAV per share HKD18.1 Adjusted NAV per share

Impairment provisions RMB23.4 billion Non-cash impairment and revaluation in 2025

Total revenue RMB173.43 billion Group revenue during 2025 reporting period

Industrial operation profit RMB4 billion Adjusted industrial operation profit, 2025

Core subsidiaries revenue RMB128.2 billion (74%) Revenue and share of group total for four core subsidiaries

Fosun Pharma net profit RMB3.371 billion Net profit attributable to parent, up 21.69% YoY

Fosun Insurance Portugal net profit EUR201 million Net profit attributable to owners, up 15.8% YoY

Historical Context

4 past events · Latest: Dec 21 (Positive)

Pattern 4 events

Date	Event	Sentiment	24h Move	Catalyst
Dec 21	ESG award recognition	Positive	+1.8%	TVB Outstanding ESG Award and related ESG practice recognition.
Nov 20	ESG leadership award	Positive	-5.2%	Bloomberg Businessweek ESG Leading Enterprise honor and high ESG ratings.
Nov 06	Innovation showcase	Positive	-5.2%	CIIE participation highlighting oncology and CAR-T therapies and new systems.
Oct 30	Consumer brand event	Positive	-5.2%	Launch of International Jewelry Fashion Theme Month in Shanghai.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent ESG and strategic news has often seen negative price reactions, with only one of four prior positive announcements aligning with a gain.

Recent Company History

Over the past six months, Fosun International has focused on ESG recognition, healthcare innovation, and brand-building initiatives. Awards from TVB, Bloomberg Businessweek/Chinese Edition, and The Asset highlighted strong ESG ratings and sustainability commitments. The company also showcased medical technologies and consumer initiatives at CIIE and in Shanghai’s jewelry and fashion district. Despite generally positive narratives, several of these events saw share price declines. Today’s results update, with large non-cash impairments but stable operating performance, fits into this pattern of balancing strategic progress with financial restructuring.

Key Terms

impairment provision, non-cash impairment, goodwill, intangible assets, +2 more

6 terms

impairment provision financial

"the RMB23.4 billion impairment provision was a "prudent accounting measure""

An impairment provision is an accounting charge a company records when an asset (like equipment, a building, or an investment) is judged to be worth less than its listed value on the balance sheet. It matters to investors because it reduces reported profit and the company’s net asset value, signaling that expected future cash flows from that asset have declined — like lowering the advertised price on a damaged car because it won’t fetch its original value.

non-cash impairment financial

"Fosun made non-cash impairment provisions and value revaluations"

A non-cash impairment is a reduction in a company's asset value that doesn't involve actual money changing hands. It happens when an asset, like equipment or a building, becomes less useful or less valuable than it was before, and the company needs to record that loss in its financial reports. This matters because it shows the true worth of what the company owns and can affect its overall financial health.

goodwill financial

"goodwill and intangible assets of certain non-core business segments"

Goodwill is the extra value a buyer pays for a company above the measurable worth of its buildings, inventory and other tangible items, reflecting things like brand reputation, customer loyalty and expected future profits. Think of paying more for a café because of its famous name and regulars rather than its furniture alone. It matters to investors because changes in goodwill — for example a write-down if expected benefits don’t materialize — can reduce reported earnings and signal that past acquisitions aren’t delivering as hoped.

View in glossary

intangible assets financial

"goodwill and intangible assets of certain non-core business segments"

Non-physical resources a company owns that help it earn money, such as brand names, patents, customer lists, proprietary software, or trade secrets — think of them as a company’s reputation, recipes, or secret formulas that aren’t bricks and mortar. Investors care because these assets can create long-term income, protect market share, and boost the value of a business even if they don’t appear as cash; strong intangible assets can mean higher future profits and lower risk of competitors copying a company’s advantages.

View in glossary

net asset value (NAV) financial

"Fosun International's adjusted net asset value (NAV) was RMB133.5 billion"

Net asset value (NAV) is the per-share value of an investment fund calculated by totaling the fund’s assets, subtracting its liabilities, and dividing the remainder by the number of outstanding shares. Think of it like a price tag on each share of a collective piggy bank: investors use NAV to see what each share is worth, to compare funds, and, for many funds, it’s the price at which shares are bought or redeemed.

share buyback program financial

"The Company's Board of Directors has announced a share buyback program."

A share buyback program is when a company uses its cash to repurchase its own outstanding shares from the market, reducing the number of shares available to investors. That matters because it can raise the value of remaining shares and signal management's confidence in the business—similar to a bakery buying back unsold loafs to make each remaining loaf represent a larger share of its oven’s output—though buybacks can also affect cash available for other uses.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

HONG KONG, March 31, 2026 /PRNewswire/ -- On the morning of 31 March, Guo Guangchang, Chairman of Fosun International, stated at Fosun International's 2025 annual results presentation that the RMB23.4 billion impairment provision was a "prudent accounting measure, not a reflection of operational issues". He described the impairment as "repairing the roof on a sunny day" and said that the management is confident in Fosun's future development.

Guo Guangchang emphasized that, from a long-term perspective, this impairment marks Fosun's entry into a new stage of development. "We will resolutely divest assets with low profitability and value below target, and focus our resources on core, high‑growth areas, steering the Company toward a leaner, healthier, and more sustainable future."

He explained that the operating results of Fosun's various business segments indicate that Fosun's core businesses remain solid. The pharmaceutical business has continued to make breakthroughs in its global expansion, with multiple products launched overseas and several promising pipeline products. The insurance business saw growth both domestically and internationally, with Fosun Insurance Portugal expanding its business into regions such as Latin America and Africa. Meanwhile, domestic insurance companies, Fosun United Health Insurance and Pramerica Fosun Life Insurance, recorded significant profit increases. In the culture and tourism business, Club Med achieved record-high results.

"These businesses are capable of generating sustainable profit and cash flow, laying the foundation for Fosun's continued growth. Following this significant impairment, Fosun's future operating results will more accurately reflect the underlying quality of our core businesses. I believe Fosun has the ability to navigate through cycles. While we may face some short-term challenges, these efforts will position Fosun for steadier, longer-term growth," said Guo Guangchang.

He stated that Fosun's management has clear expectations and full confidence in the Company's future development. Fosun International's adjusted net asset value (NAV) was RMB133.5 billion, with a NAV per share reaching HKD18.1. The Company's Board of Directors has announced a share buyback program. Fosun's major shareholder and management team will also increase their holdings in the shares of the Company. In the future, Fosun will actively explore and gradually introduce further measures to reward shareholders, including optimizing the dividend mechanism, in line with operational improvements and cash flow conditions.

On the evening of 30 March, Fosun International announced its 2025 annual results. During the Reporting Period, the Group's total revenue reached RMB173.43 billion, and adjusted industrial operation profit was RMB4 billion. Its four core subsidiaries generated RMB128.2 billion in revenue, accounting for 74% of the Group's total revenue. Among them, Fosun Pharma achieved a net profit attributable to shareholders of the parent of RMB3.371 billion, representing a year-on-year increase of 21.69%. Fosun Insurance Portugal achieved a net profit attributable to owners of the parent of EUR201 million, up 15.8% year-on-year.

Compared to prior years, Fosun's results have largely remained stable. However, Fosun made non-cash impairment provisions and value revaluations on certain real estate projects with impairment indicators and goodwill and intangible assets of certain non-core business segments, resulting in a book loss of RMB23.4 billion in 2025, of which real estate-related impairment accounted for approximately 55%, while impairment of non-core assets accounted for approximately 45%.

View original content:https://www.prnewswire.com/news-releases/guo-guangchang-fosun-internationals-nav-reaches-hkd18-1-per-share-focusing-resources-on-core-highgrowth-areas-302729791.html

SOURCE Fosun

FAQ

What is Fosun International's NAV per share reported on March 31, 2026 (FOSUF)?

The NAV per share reported was HKD18.1, reflecting adjusted net assets of RMB133.5 billion. According to the company, this adjusted NAV accounts for asset revaluations and impairment provisions taken in 2025.

How large was Fosun's 2025 impairment and what caused the loss (FOSUF)?

Fosun recorded a RMB23.4 billion non-cash book loss in 2025, driven by impairments and revaluations. According to the company, about 55% related to real estate and 45% to non-core goodwill and intangible assets.

Did Fosun announce shareholder returns like buybacks or dividends on March 31, 2026 (FOSUF)?

Yes. The Board announced a share buyback program and said major shareholders and management will increase holdings. According to the company, further shareholder reward measures, including dividend optimization, will be explored.

What were Fosun's 2025 revenue and adjusted industrial operation profit (FOSUF)?

Fosun reported RMB173.43 billion in total revenue and RMB4.0 billion adjusted industrial operation profit for 2025. According to the company, four core subsidiaries contributed RMB128.2 billion, or 74% of total revenue.

How did Fosun's core subsidiaries perform in 2025, including Fosun Pharma and Fosun Insurance Portugal (FOSUF)?

Fosun Pharma posted net profit of RMB3.371 billion (+21.69% YoY); Fosun Insurance Portugal reported EUR201 million net profit (+15.8% YoY). According to the company, core businesses delivered sustainable profit and cash flow.

What strategic changes did chairman Guo Guangchang announce for Fosun after the 2025 results (FOSUF)?

Chairman Guo said Fosun will divest low-profit assets and reallocate resources to core, high-growth areas to become leaner and more sustainable. According to the company, this follows the impairment and aims to improve future operating quality.